Nelarabine Injection
Product Images NDC 71288-165

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 71288-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nel01 0000 01 V2)

FDA Label Image

Principal Display Panel – Nelarabine Injection 50 mL Vial Label (Nel01 0000 02 V2)

FDA Label Image

Principal Display Panel – Nelarabine Injection 50 mL Carton (Nel01 0000 03 V3)

Principal Display Panel – Nelarabine Injection 50 mL Carton (Nel01 0000 03 V3)
This is a description of a medication product called Nelarabine Injection. It contains 5 mg of Nlaratine and 4.5 mg of sodium chloride, and is used for intravenous infusion only. The product comes in 50 mL single-dose vials and should be discarded after use. The usual dosage instructions are provided in the package insert. The medication is sterile, non-pyrogenic, and preservative-free. It is important to store the product between 20°C and 25°C and not to use it if the plastic overseal is missing or not securely fitted. The manufacturer's code (NDC) for the product is 71288.165-53.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.